南方医科大学学报

南方医科大学学报 ›› 2023, Vol. 43 ›› Issue (9): 1622-1628.doi: 10.12122/j.issn.1673-4254.2023.09.21

• • 上一篇    下一篇

生命潮生物反馈技术干预2型糖尿病的先导观察

刘 泽，何汶霞，房睿哲，肖 钢，言 芳，邱祁广，方会龙，王俊杰   

  1. 湘南学院护理学院，医学影像检验与康复学院，基础医学院，药学院，湖南 郴州 423000；北京道贞健康科技发展有限责任公司，北京 100000；郴州市帛道健康管理有限公司，湖南 郴州 423000
  • 出版日期:2023-09-20 发布日期:2023-09-28

Lifetide biofeedback intervention in type 2 diabetic patients: a pilot observation

LIU Ze, HE Wenxia, FANG Ruizhe, XIAO Gang, YAN Fang, QIU Qiguang, FANG Huilong, WANG Junjie   

  1. School of Nursing, School of Medical Imaging Testing and Rehabilitation, College of Basic Medicine, College of Pharmacology, Xiangnan University, Chenzhou 423000, China; Beijing Daozhen Health Technology Development Co. Ltd., Beijing 100000, China; Chenzhou Bodao Health Management Company, Chenzhou 423000, China
  • Online:2023-09-20 Published:2023-09-28

RichHTML

15

PDF

228

摘要： 目的 探讨生命潮生物反馈技术对2型糖尿病（T2DM）的治疗效果，为T2DM的临床治疗提供新技术。方法 分析5例T2DM患者经生命潮生物反馈技术干预治疗后平均血糖、预估糖化血红蛋白（HbA1c）、空腹血糖及HbA1c的变化情况，干预期间联合瞬感血糖监测系统进行减药管理。结果 与干预前使用降糖药相比，经干预治疗停用降糖药物后，其平均血糖、空腹血糖及HbA1c的差异无统计学意义（P>0.05），但预估HbA1c较干预前使用降糖药时明显降低（P<0.05）；干预治疗后2例患者实现完全缓解，2例患者实现部分缓解，1例患者血糖得到明显改善；有1例患者经干预后其手足末端温度升高（P<0.05）；另有1例患者经干预后心率的差异无统计学意义（P>0.05），但心率变异性指数升高（P<0.05）。结论 生命潮生物反馈技术可通过促进自主神经系统调控平衡及改善微循环，在不改变原有生活方式下，帮助T2DM患者停用降糖药，维持血糖稳定，实现疾病缓解，降低并发症的发生。

关键词: 生命潮生物反馈；2型糖尿病；缓解

Abstract: Objective To evaluate the therapeutic efficacy of lifetide biofeedback intervention in patients with type 2 diabetes mellitus (T2DM). Methods We analyzed the changes in average blood glucose, estimated glycosylated hemoglobin (HbA1c), fasting blood glucose and HbA1c levels in 5 patients with T2DM undergoing lifetide biofeedback intervention without the use of hypoglycemic drugs. A transient blood glucose monitoring system was used for drug withdrawal management during the intervention. Results Compared with those before the intervention, the average blood glucose and fasting blood glucose and HbA1c levels showed no significant changes after the intervention without using hypoglycemic drugs (P>0.05), but the estimated HbA1c was significantly decreased after the intervention (P<0.05). Two patients achieved complete remission, two showed partial remission, and one had substantially improved blood glucose levels. One patient showed a marked increase in extremity temperature after the intervention (P<0.05). Another patient had a significantly increased heart rate variability index (P<0.05) without obvious changes in heart rate after the intervention (P>0.05). Conclusion By reestablishing the balance in autonomic nervous system regulation and enhancing peripheral microcirculation, lifetide biofeedback intervention helps to maintain stable blood glucose levels, achieve disease remission, and reduce the occurrence of complications in T2DM patients after discontinuation of hypoglycemic drugs without changing their lifestyles.

Key words: lifetide biofeedback; type 2 diabetes mellitus; remission